Nuklearmedizin 2010; 49(05): N41-N43
DOI: 10.1055/s-0038-1626515
Case report
Schattauer GmbH

Advanced inoperable type B3 thymoma: Monitoring of a novel therapeutic approach with radio-chemo therapy and sorafenib by FDG-PET and CT

T. Winder
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
7   Private University in the Principality of Liechtenstein
,
A. Schuster
3   Department of Radiology, Academic Teaching Hospital Feldkirch, Austria
,
A. Becherer
4   Department of Nuclear Medicine, Academic Teaching Hospital Feldkirch, Austria
,
K. Gasser
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
7   Private University in the Principality of Liechtenstein
,
A. De Vries
5   Department of Radiotherapy, Academic Teaching Hospital Feldkirch, Austria
,
U. Gruber-Moesenbacher
6   Department of Pathology, Academic Teaching Hospital Feldkirch, Austria
,
A. Muendlein
2   Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
7   Private University in the Principality of Liechtenstein
,
H. Drexel
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
7   Private University in the Principality of Liechtenstein
8   Drexel University College of Medicine, Philadelphia, PA, USA
,
A. Lang
1   Department of Medicine, Academic Teaching Hospital Feldkirch, Austria
2   Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria
› Author Affiliations
Further Information

Publication History

Received: 29 March 2010

accepted in revised form: 21 May 2010

Publication Date:
25 January 2018 (online)

Preview